xevinapant
merck
['head and neck', 'headandneck', 'serono']
 presented the results from the phase ii study of xevinapant + chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck at the 2022. read more: #headandneckcancer #esmo2022 #esmo #esmo22 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry